• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[雄激素受体异构体在人前列腺中的表达及其新cDNA克隆]

[Androgen receptor isoforms expression and its novel cDNA cloning in human prostate].

作者信息

Xia S, Wang Y, Tang X

机构信息

Department of Urology, Shanghai First People's Hospital, Shanghai 200080, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2001 Dec 25;81(24):1500-3.

PMID:16200775
Abstract

OBJECTIVE

To investigate the androgen receptor isoforms expression and its novel eDNA cloning in prostate tissue.

METHODS

The tissue from a case of benign prostatic hyperplasia (BPH) was analyzed by high resolution isoelectric focusing (IEF) technique and molecular biological technique of cDNA cloning was used to determine its AR isoforms expression and genes of AR isoforms.

RESULTS

From the prostatic specimen, three types of AR isoforms were detected with pI values of 6.5, 6.0 and 5.3 respectively. A novel AR subtype cDNA cloning, named as PHAR-1 and including 1 913 nucleotides was isolated from the same BPH tissue. The GenBank accession number for the nucleotide sequence of this AR cDNA was BankIT372205 AF324243. The comparison between PHAR-1 and AR nucleotide sequence registered in GenBank showed that 961 nucleotides in three part of nucleotide sequence were the same, while the other 952 nucleotides were different.

CONCLUSION

These three AR isoforms may originate from the same gene. The results may be important for the study of BPH, or prostatic growth. It is also valuable in the field of pharmacotherapy for treatment of BPH and prostatic cancer.

摘要

目的

研究前列腺组织中雄激素受体异构体的表达及其新的 cDNA 克隆。

方法

采用高分辨率等电聚焦(IEF)技术分析 1 例良性前列腺增生(BPH)患者的组织,并运用 cDNA 克隆的分子生物学技术来确定其雄激素受体异构体的表达及基因。

结果

在前列腺标本中检测到三种类型的雄激素受体异构体,其等电点(pI)值分别为 6.5、6.0 和 5.3。从同一 BPH 组织中分离出一种新的雄激素受体亚型 cDNA 克隆,命名为 PHAR - 1,包含 1913 个核苷酸。该雄激素受体 cDNA 的核苷酸序列在 GenBank 中的登录号为 BankIt372205 AF324243。将 PHAR - 1 与 GenBank 中登记的雄激素受体核苷酸序列进行比较,结果显示核苷酸序列的三个部分中有 961 个核苷酸相同,而另外 952 个核苷酸不同。

结论

这三种雄激素受体异构体可能源自同一基因。这些结果可能对 BPH 或前列腺生长的研究具有重要意义。在 BPH 和前列腺癌的药物治疗领域也具有重要价值。

相似文献

1
[Androgen receptor isoforms expression and its novel cDNA cloning in human prostate].[雄激素受体异构体在人前列腺中的表达及其新cDNA克隆]
Zhonghua Yi Xue Za Zhi. 2001 Dec 25;81(24):1500-3.
2
Androgen receptor isoforms in human and rat prostate.
Asian J Androl. 2000 Dec;2(4):307-10.
3
[Expression of androgen receptor isoforms in normal human prostate].[雄激素受体亚型在正常人类前列腺中的表达]
Zhonghua Nan Ke Xue. 2003 Oct;9(7):501-3, 506.
4
[Androgen receptor isoforms in LNCaP cell and human prostate].[LNCaP细胞和人前列腺中的雄激素受体亚型]
Zhonghua Nan Ke Xue. 2002;8(3):169-72.
5
Androgen receptor isoforms in human prostatic cancer tissue and LNCaP cell line.人前列腺癌组织和LNCaP细胞系中的雄激素受体亚型
Asian J Androl. 2001 Sep;3(3):223-5.
6
[Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].[雄激素受体在正常前列腺、良性前列腺增生及前列腺癌中的表达]
Zhonghua Nan Ke Xue. 2010 Nov;16(11):967-72.
7
[Expression of sexual hormon receptors in prostatic cancer tissues].
Zhonghua Nan Ke Xue. 2006 Jan;12(1):50-2, 56.
8
Differential expression and function of AR isoforms in prostate cancer.雄激素受体异构体在前列腺癌中的差异表达和功能。
Oncol Rep. 2012 Feb;27(2):492-8. doi: 10.3892/or.2011.1516. Epub 2011 Oct 21.
9
Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators.建立一种稳定表达雄激素受体的新型永生化人前列腺上皮细胞系及其在雄激素受体调节剂功能筛选中的应用。
Biochem Biophys Res Commun. 2009 May 15;382(4):756-61. doi: 10.1016/j.bbrc.2009.03.110. Epub 2009 Mar 24.
10
Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.以二苯甲酰甲烷抑制雄激素受体表达作为晚期前列腺癌的治疗目标。
Anticancer Res. 2007 May-Jun;27(3B):1483-8.